New treatment for hepatitis C in chronic kidney disease, dialysis, and transplant.
about
Early Results of Pilot Study Using Hepatitis C Virus (HCV) Positive Kidneys to Transplant HCV Infected Patients with End-Stage Renal Disease Allowing for Successful Interferon-Free Direct Acting Antiviral Therapy after Transplantation.Small-molecule inhibitors of hepatitis C virus (HCV) non-structural protein 5A (NS5A): a patent review (2010-2015).Why and how to measure renal function in patients with liver disease.Therapy with ombitasvir/paritaprevir/ritonavir plus dasabuvir is effective and safe for the treatment of genotypes 1 and 4 hepatitis C virus (HCV) infection in patients with severe renal impairment: A multicentre experience.Diagnosis and Management of Hepatitis C Infection in Primary Care Settings.Hepatitis C and renal transplantation in era of new antiviral agents
P2860
New treatment for hepatitis C in chronic kidney disease, dialysis, and transplant.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
New treatment for hepatitis C in chronic kidney disease, dialysis, and transplant.
@en
type
label
New treatment for hepatitis C in chronic kidney disease, dialysis, and transplant.
@en
prefLabel
New treatment for hepatitis C in chronic kidney disease, dialysis, and transplant.
@en
P2093
P1433
P1476
New treatment for hepatitis C in chronic kidney disease, dialysis, and transplant.
@en
P2093
Fabrizio Fabrizi
Paul Martin
Piergiorgio Messa
P304
P356
10.1016/J.KINT.2016.01.011
P407
P577
2016-03-11T00:00:00Z